Bruker Receives FDA Clearance for the MALDI Biotyper Microbial Identification System
Bruker Corporation announced that it has been granted U.S. FDA clearance under Section 510(k) to m…
Bruker Corporation announced that it has been granted U.S. FDA clearance under Section 510(k) to m…
Led by the Basque R&D Alliance IK4, 13 organisations in 8 different countries have been conducti…
PathoGenetix, Inc., a developer of an automated system for bacterial strain typing, and Marshfield F…
A rapid and sensitive assay requiring no special equipment can detect Chlamydia trachomatis directly…
bioMérieux,Inc a world leader in the field of in vitro diagnostics, is pleased to announce that EMSL…
The revelation of a new optical dimension in nanophotonics offers untapped clinical potential in non…
Researchers have developed a glass/silicon polymer chip with a microscopically small channel that en…
A new rapid tuberculosis test shortens diagnosis time on one of the world’s deadliest diseases from …
Researchers at King’s College London have identified a biomarker – a biological ‘fingerprint’ – for …
Researchers have developed a new assay for rapid and sensitive detection of Chlamydia trachomatis, t…
Researchers in Denmark have found that using whole-genome sequencing directly on clinical samples id…
The U.S. Food and Drug Administration (FDA) has issued the Final Rule “Prevention of Salmonella Ente…
NanoLogix, Inc., an innovator in the rapid detection, identification of live bacteria, and determina…
BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology…